Rocket Pharma To Buy Renovacor For $2.60/ Share In Stock
Rocket Pharmaceuticals, Inc. (RCKT), a late-stage, clinical biotechnology company with genetic therapies for rare childhood disorders, Tuesday announced its agreement to acquire Renovacor, Inc. (RCOR), which is focused on AAV-based … Read More